Literature DB >> 17452235

Sulfonylurea-responsive diabetes in childhood.

Zohar Landau1, Julio Wainstein, Aaron Hanukoglu, Myriam Tuval, Judith Lavie, Benjamin Glaser.   

Abstract

We describe a family in which 3/6 siblings had transient, relapsing neonatal diabetes. The father and another sibling had diabetes diagnosed at 20 and 9 years old, respectively. All affected individuals carried the same KCNJ11 gene mutation. In all, sulfonylurea treatment permitted cessation of insulin treatment, with improved glycemic control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452235     DOI: 10.1016/j.jpeds.2007.03.004

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  K(ATP) channel pharmacogenomics: from bench to bedside.

Authors:  S Sattiraju; S Reyes; G C Kane; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

Review 2.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

Review 3.  Neonatal diabetes mellitus.

Authors:  Lydia Aguilar-Bryan; Joseph Bryan
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

4.  Permanent neonatal diabetes mellitus: same mutation, different glycemic control with sulfonylurea therapy on long-term follow-up.

Authors:  Banu Kücükemre Aydin; Rüveyde Bundak; Firdevs Baş; Hülya Maraş; Nurçin Saka; Hülya Günöz; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

5.  Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.

Authors:  Amélie Bonnefond; Julien Philippe; Emmanuelle Durand; Aurélie Dechaume; Marlène Huyvaert; Louise Montagne; Michel Marre; Beverley Balkau; Isabelle Fajardy; Anne Vambergue; Vincent Vatin; Jérôme Delplanque; David Le Guilcher; Franck De Graeve; Cécile Lecoeur; Olivier Sand; Martine Vaxillaire; Philippe Froguel
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.